Genomewide Linkage Analysis of Bipolar Disorder by Use of a High-Density Single-Nucleotide–Polymorphism (SNP) Genotyping Assay: A Comparison with Microsatellite Marker Assays and Finding of Significant Linkage to Chromosome 6q22  by Middleton, F.A. et al.
Am. J. Hum. Genet. 74:886–897, 2004
886
Genomewide Linkage Analysis of Bipolar Disorder by Use of a High-
Density Single-Nucleotide–Polymorphism (SNP) Genotyping Assay: A
Comparison with Microsatellite Marker Assays and Finding of Signiﬁcant
Linkage to Chromosome 6q22
F. A. Middleton,1,2,3 M. T. Pato,2,3,4 K. L. Gentile,1,2 C. P. Morley,2 X. Zhao,1,2 A. F. Eisener,2
A. Brown,1,2 T. L. Petryshen,6 A. N. Kirby,5,6 H. Medeiros,2,4 C. Carvalho,2 A. Macedo,8
A. Dourado,8 I. Coelho,8 J. Valente,8 M. J. Soares,8 C. P. Ferreira,9 M. Lei,9 M. H. Azevedo,4
J. L. Kennedy,10 M. J. Daly,5 P. Sklar,6,7 and C. N. Pato2,3,4,9
1Department of Neuroscience and Physiology, 2Center for Psychiatric and Molecular Genetics, and 3Department of Psychiatry, State
University of New York (SUNY), Syracuse, NY; 4Veterans Administration Medical Center, Washington, DC; 5Whitehead Institute and 6Broad
Institute, Cambridge, MA; 7Psychiatric and Neurodevelopmental Genetics Unit, Harvard Medical School, Charlestown, MA; 8Psicologia
Medica, Universidade de Coimbra, Coimbra, Portugal; 9Psychiatry Service, Ponta Delgada, Azores, Portugal; and 10Clarke Division, Centre for
Addiction and Mental Health, Toronto
We performed a linkage analysis on 25 extended multiplex Portuguese families segregating for bipolar disorder, by
use of a high-density single-nucleotide–polymorphism (SNP) genotyping assay, the GeneChip Human Mapping 10K
Array (HMA10K). Of these families, 12 were used for a direct comparison of the HMA10K with the traditional
10-cM microsatellite marker set and the more dense 4-cM marker set. This comparative analysis indicated the
presence of signiﬁcant linkage peaks in the SNP assay in chromosomal regions characterized by poor coverage and
low information content on the microsatellite assays. The HMA10K provided consistently high information and
enhanced coverage throughout these regions. Across the entire genome, the HMA10K had an average information
content of 0.842 with 0.21-Mb intermarker spacing. In the 12-family set, the HMA10K-based analysis detected
two chromosomal regions with genomewide signiﬁcant linkage on chromosomes 6q22 and 11p11; both regions
had failed to meet this strict threshold with the microsatellite assays. The full 25-family collection further strength-
ened the ﬁndings on chromosome 6q22, achieving genomewide signiﬁcance with a maximum nonparametric linkage
(NPL) score of 4.20 and a maximum LOD score of 3.56 at position 125.8 Mb. In addition to this highly signiﬁcant
ﬁnding, several other regions of suggestive linkage have also been identiﬁed in the 25-family data set, including
two regions on chromosome 2 (57 Mb, NPL p 2.98; 145 Mb, NPL p 3.09), as well as regions on chromosomes
4 (91 Mb, NPL p 2.97), 16 (20 Mb, NPL p 2.89), and 20 (60 Mb, NPL p 2.99). We conclude that at least
some of the linkage peaks we have identiﬁed may have been largely undetected in previous whole-genome scans
for bipolar disorder because of insufﬁcient coverage or information content, particularly on chromosomes 6q22
and 11p11.
Introduction
We recently reported the identiﬁcation of several chro-
mosomal regions suggestive of linkage, found in an initial
genome scan of 16 multiplex Portuguese families who
segregated for bipolar disorder (Pato et al., in press). As
a follow-up study, we examined 25 extended families
from the same population (including 12 of the original
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16 families with sufﬁcient DNA available) by use of a
new high-density genotyping assay, the GeneChipHuman
Mapping 10K Array (HMA10K) (Affymetrix). This assay
permits the simultaneous genotyping of 11,560 SNPs,
spaced throughout the human genome at a median in-
termarker distance of 210 kb (Kennedy et al. 2003). Each
SNP in this assay is interrogated by a distinct set of mul-
tiple overlapping probes for each allele and each DNA-
strand orientation. SNPs represent variations in DNA se-
quence that can be mapped to reveal patterns of genetic
transmission within pedigrees. Such inheritance patterns
can be instrumental in linkage or linkage-disequilibrium
analyses of simple or complex phenotypes.
Bipolar disorder affects ∼1% of the worldwide pop-
ulation and shows strong evidence of heritability (Tsuang
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and Farone 1990). The search for candidate genes in
bipolar disorder has traditionally been focused on studies
of large extended pedigrees, extensive sib-pair collections,
and a variety of family-based and population-based as-
sociation studies (Ewald et al. 2002; Sklar 2002; Dick et
al. 2003; Segurado et al. 2003). Over the past 10 years,
we have developed the Portuguese Island Collection to
study the genetics of bipolar disorder and schizophrenia
in a relatively homogeneous population (Pato et al.
1997). The strategy of using a population isolate and
nearly complete ascertainment of multiplex families pro-
vides a uniquely powerful and informative study popu-
lation for complex genetic disorders (Peltonen 2000). Fo-
cused on the Azorean and Madeiran islands, this study
beneﬁts from the unique parallel history of these two
archipelagoes (Pato et al. 2000; Lewis et al. 2003; re-
viewed by Sklar et al. 2004). For example, we recently
reported linkages of schizophrenia to chromosome 5q
(Sklar et al. 2004), a region strongly implicated from a
meta-analysis of 20 genomewide scans (Lewis et al.
2003).
The linkage results that were reported from the
whole-genome scan for bipolar disorder in 16 families
from the Portuguese population revealed three regions
on chromosomes 2, 11, and 19 with genomewide sug-
gestive linkage and several other regions, including
chromosome 6q (marker D6S1021), that also ap-
proached suggestive signiﬁcance (Pato et al., in press).
Higher-density mapping with microsatellite markers at
4.2-cM spacing showed a nonparametric linkage (NPL)
score of 2.59 at this same marker and an additional
peak at D6S1639 (125 Mb), with an NPL score of 3.06
(Pato et al., in press). The ﬁnding on 6q was noted in
that study since it replicated the ﬁndings of the National
Institute of Mental Health (NIMH) Genetics Initiative
(see Dick et al. 2003). Those authors reported in a study
of 250 families with bipolar disorder a maximum LOD
score of 2.2 at marker D6S1021 (104.7Mb) on chro-
mosome 6q; this LOD score was subsequently raised to
a genomewide signiﬁcance level of 3.8 in a combined
analysis of all 399 pedigrees with bipolar disorder from
the authors’ collection. Here we report the results of an
HMA10K assay in 25 Portuguese families with bipolar
disorder, and we present a direct comparison of low-
and intermediate-density microsatellite scans with the
HMA10K in 12 of these families for the two chromo-
somes (6 and 11) with the most signiﬁcant results. Our
data indicate that the signiﬁcant linkage peaks we have
identiﬁed with the HMA10K assay may have been
largely undetected or underestimated in terms of their
signiﬁcance because of insufﬁcient coverage or infor-
mation content of the microsatellite assays, and we ar-
gue strongly in favor of future whole-genome scanswith
the HMA10K assay.
Material and Methods
Subjects
Families were ascertained from the systematic screening
of clinicians, treatment facilities, social services, and ex-
tensive family interviews. In the Azores, all four psychi-
atric hospitals and the two general hospitals participated
in the study. Similarly, in Madeira, both psychiatric hos-
pitals and the general hospital participated. On the main-
land, families were identiﬁed by collaborators at the Uni-
versity of Coimbra. Informed consent was obtained from
participants in the genetic and family studies. Collection
of blood and family history information was approved
by all of the appropriate institutional review boards. On
the islands, families were ascertained if both of the pro-
band’s parents and all four of the grandparents were na-
tive to the islands. Diagnoses were made from data ob-
tained with the Diagnostic Interview for Genetic Studies
(DIGS) (Nurnberger et al. 1994). Interviews were per-
formed at the site of the subject’s clinical care, in the
subject’s home, or at an alternate site of the subject’s
choosing. Interviewers were highly trained psychiatrists,
psychologists, or social workers. Interrater reliability was
assured by careful training and evaluation of each inter-
viewer prior to the onset of the study and annually there-
after. Reliability was assessed periodically through the in-
dependent assessment of 12 subjects by interviewers from
different study sites and by a senior supervisor. The
chance-corrected interrater agreement, k,was high for the
diagnoses of schizophrenia, bipolar disorder, and schi-
zoaffective disorder ( –0.94). Items related to thekp 0.9
diagnosis of schizotypy showed slightly less agreement
( ). Thorough clinical narratives were com-kp∼ 0.75
pleted for all subjects. Best-estimate diagnoses according
to the Diagnos tic and Statistical Manual, fourth edition
(DSM-IV), were made by two independent blinded re-
searchers after review of clinical information, the DIGS,
the Operational Criteria Checklist for Psychotic Illness
(McGufﬁn et al. 1991), andwritten narratives. Caseswith
disparate diagnoses were reviewed by a third senior psy-
chiatrist blind to the case status (M.T.P.).
We used a total of 25 families for linkage analysis in
the present study. These families were represented by
pedigrees that included 233 individuals (83 founders,
150 nonfounders). The mean family size was 9.32 (range
4–17; mode 5), spanning a mean of 2.88 generations
(range 2–4; mode 3). In these families, we ran a total of
148 HMA10K assays, with samples from 88 female and
60 male subjects. The mean number of assays per family
was 5.9 (range 3–11; mode 8). Full deﬁnitive diagnoses
were available for 140 of the 148 subjects, with the
remainder of subjects analyzed using the “unknown”
phenotype. Of the affected subjects, 73 were diagnosed
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with bipolar disorder and 2 were diagnosed with schizo-
affective-bipolar disorder, representing a mean of 3.0
affected subjects per family. Of the 25 families, 15 were
from the Azores, 5 from Madeira, and 5 from the city
of Coimbra on the Portuguese mainland. To compare
the HMA10K assay with microsatellite assays, we per-
formed linkage analysis using the same individuals in 12
of the 25 families. These 12 families had been used in
a previous microsatellite study of bipolar disorder in-
volving 16 families (Pato et al., in press) and represented
all families with sufﬁcient DNA available from that
study. These 12 families included 107 subjects (36 foun-
ders, 71 nonfounders) with a mean family size of 8.92
(range 5–17; mode 7), spanning 2.75 generations (range
2–4; mode 3). A total of 68 subjects were used for the
comparisons (29males, 39 females). Deﬁnitive diagnoses
were available for 66 of the subjects. A total of 35 sub-
jects were diagnosed with bipolar or schizoaffective-bi-
polar disorder (mean 2.91 affected individuals per fam-
ily). Of the 12 families, 8 were from the Azores, 1 was
from Madeira, and 3 were from Coimbra.
DNA Isolation
DNA was isolated from 10 ml of venous blood col-
lected from subjects in the clinic or in their homes. Next,
1 vol of blood and 3 vol of ice-cold 1# Miller’s RBCL
(155 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2 EDTA)
were added to a 50-ml conical-bottom polypropylene
tube and inverted several times. Tubes were placed on
ice for 30 min, inverted several times throughout the
incubation, and centrifuged (2,500 rpm, 15 min, 40C).
The supernatant was decanted, the sample pellet was
resuspended in 30 ml of 1# Miller’s RBCL, and it was
then centrifuged again (2,500 rpm, 15 min, 40C). The
supernatant was again decanted, the pellet resuspended,
and the sample digested with 30 ml of proteinase K (20
mg/ml) overnight at 42C, with constant shaking (100
rpm). After digestion, 3 ml of 8M ammonium acetate
were added to each sample to precipitate proteins, fol-
lowed by vortexing for 30 s. Each sample was then cen-
trifuged in a swinging bucket rotor (3,500 rpm, 10 min,
25C), and the cleared supernatant was transferred to a
new 50-ml tube. The puriﬁed DNA was precipitated
with 2 vol of ice-cold 100% ethanol, centrifuged (2,500
rpm, 10 min, 40C), and washed with 1 vol of 70%
ethanol, followed by centrifugation (2,500 rpm, 5 min,
40C). After the ﬁnal wash was decanted, pellets were
air dried (30 min, 25C) and resuspended in 350 ml of
Tris-EDTA containing 1 ml RNase A (Sigma). The yield
and purity of each sample was assessed using UV
spectrophotometry.
DNA Preparation for Human Mapping Assay
Samples were processed according to the GeneChip
Mapping Assay Manual (Affymetrix). First, 250 ng of
genomic DNA in reduced EDTA TE buffer (10 mMTris-
HCl, pH 8.0; 0.1 mM EDTA, pH 8.0) was digested with
XbaI (New England Biolabs) for 2 h at 37C. The en-
zyme was inactivated by incubation at 70C for 20 min.
The Adaptor Xba (Affymetrix) was then ligated to the
digested DNA with T4 DNA ligase at 16C for 2 h and
inactivated at 70C for 20 min. Each ligation reaction
was diluted with 75 ml water. For each sample, 10 ml of
the diluted ligation reaction was added to four separate
100-ml PCR reactions (1# PCR buffer II [Applied Bio-
systems]; 250 mM dNTP [Panvera Takara]; 2.5 mM
MgCl2 [Applied Biosystems]; 0.75 mM PCR primer Xba
[Affymetrix]; 0.1 U/ml AmpliTaq Gold [Applied Bio-
systems]). The PCR was run on an MJ DNA Engine
Tetrad thermal cycler (initial denaturation at 95C for
3 min; 35 cycles of 95C for 20 s, 59C for 15 s, 72C
for 15 s; ﬁnal extension at 72C for 7 min; hold 4C).
PCR products were run on a 2% Tris-Acetate-EDTA
(TAE) gel and then puriﬁed with QIAquick spin columns
(Qiagen). Each PCR reaction was puriﬁed in a separate
column, but the same buffer eluate was used for each
column to concentrate the samples. Of this puriﬁed PCR
product, a 20-mg portion was fragmented (1# frag-
mentation buffer, 0.24 U fragmentation reagent [Affy-
metrix]) by incubating at 37C for 30 min, and then at
95C for 15 min. The fragmented PCR products were
run on a 4% TAE gel to conﬁrm optimal fragmentation
(products appear as smears !150 bp in length). The frag-
mented product was then end-labeled (1# terminal
deoxynucleotidyl transferase [TdT] buffer, 0.143 mM
GeneChip DNA labeling reagent, 1.5 U/ml TdT [Affy-
metrix]) at 37C for 2 h and inactivated at 95C for 15
min. A hybridization cocktail containing 0.056 M MES
stock (1.22 M MES, 0.89 M [Na]), 5% DMSO, 2.5#
Denhardt’s, 5.77 mM EDTA, 0.115 mg/ml herring
sperm DNA, 11.5 mg/ml human CotI, 0.0115% Tween-
20, 2.69 M tetramethyl ammonium chloride, and 2ml
oligonucleotide control reagent (Affymetrix) was added
to the labeled DNA and then heated at 95C for 10 min
to denature. The reactions were cooled on ice for 10 s
and then incubated at 48C for 2 min. Each sample was
then added to a HMA10K and hybridized at 48C for
16 h in an Affymetrix GeneChip Hybridization Oven at
60 rpm. After 16 h, the probe arrays were washed and
stained according to the GeneChipMapping AssayMan-
ual by use of the DNAARRAY_WS2 protocol on the
Affymetrix Fluidics Station 400. Arrays were scanned
once with the Agilent GeneArray 2500 scanner and an-
alyzed with Affymetrix GeneChip DNA Analysis Soft-
ware (GDAS) to generate genotype calls for each of the
SNP probes on the array.
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Table 1
Assay Performance Summary across 25 Families (148
Samples)
CALL RATE (%)
Total
For
Linkage
Signal
By Genotype
AA AB BB
Mean (%) 96.92 99.06 33.06 34.25 32.69
SD (%) 3.46 1.73 .6 1.1 .63
Figure 1 Comparison of SNP call rate across 25 families used in the biopolar study. The mean SE of the SNP call rate for each of the
families included in our study is shown. The order of the X-axis is arbitrary and reﬂects undisplayed family ID numbers. We note that 20 of
the 25 families had a mean call rate of 97%. Analysis of the families with the lowest call rates revealed a potential interaction of the sample
age and/or handling with optimal assay performance.
Linkage Analysis of HMA10K and Microsatellite
Genotype Data
We used MERLIN (Multipoint Engine for Rapid Like-
lihood Inference) software (Abecasis et al. 2002) to an-
alyze the compiled pedigree structures of the 25-family
and 12-family data sets, to examine the information con-
tent of the HMA10K and microsatellite assays in these
sets, and to perform multipoint NPL analysis. For the
SNP assays, output ﬁles from GDAS were converted for
use in MERLIN using a custom-written program
(GenPed, available from F.A.M.). MERLIN implements
the Whittemore and Halpern (1994) algorithm to test for
allele sharing among affected individuals and also cal-
culates a nonparametric LOD score by use of the Kong
and Cox (1997) linear model. Both the NPL Z scores and
LOD scores were extracted from the MERLIN runs and
used to generate graphical plots of the whole-genome scan
results. All data presented are plotted using physical po-
sitions speciﬁed in the July 2003 freeze of the University
of California–Santa Cruz (UCSC) human genome assem-
bly (UCSC Genome Bioinformatics). To generate empir-
ical P values for the present analysis, we used MERLIN
to simulate genotype data for the HMA10K, assay and
the 10-cM and 4-cM microsatellite assays, with the same
structures as the 25- and 12-family data sets. With each
of the four data sets, 100 genomewide simulations were
performed, and the resulting simulated data was analyzed
with MERLIN; the highest NPL Z and LOD scores were
recorded for each chromosome for each simulation. For
the 25-family HMA10K data set, empirical limits for ge-
nomewide signiﬁcance were established at 3.85 and 3.0
for NPL Z and LOD values, respectively, with suggestive
levels of 2.89 and 1.92. For the 12-family HMA10K data
set, empirical limits for genomewide signiﬁcance were an
NPL score of 4.05 and a LOD score of 2.6,with suggestive
level thresholds of 3.05 and 1.84, respectively. For the
10-cM microsatellite data set, empirical limits for ge-
nomewide signiﬁcance were an NPL score of 3.17 and a
LOD score of 2.12, with suggestive level thresholds of
2.40 and 1.52, respectively. For the 4-cM microsatellite
data set, empirical limits for genomewide signiﬁcance
were an NPL score of 3.40 and a LOD score of 2.11,
with suggestive level thresholds of 2.48 and 1.53, re-
spectively. These genomewide signiﬁcance thresholds rep-
resent the NPL and LOD values that could be achieved
by chance in our data set at a frequency of 0.05 (1 in 20
simulations), whereas the suggestive thresholds represent
the values that could be obtained by chance at a frequency
of once per genome scan.
Results
Assay Performance
In the 25-family data set, the HMA10K assay was per-
formed a total of 148 times on samples from 60 male and
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Table 2
Regions of Genomewide Suggestive and Signiﬁcant NPL Scores in the 12- and 25-Family Data Sets
CHROMOSOME AND
POSITION (Mb)
NPL SCORE IN SAME 12 FAMILIES FOR
NPL SCORE IN 25
FAMILIES FOR
10-cM Microsatellite
Marker Assay
4-cM Microsatellite
Marker Assay HMA10K HMA10K
2:
38: 2.18 ND 3.15 1.83
57: .44 ND 1.99 2.98
145: 2.19 ND 2.73 3.09
4:
91: .43 ND 1.33 2.97
6:
104: 1.96 1.88 1.92 1.86
127: .79 1.16 3.87 4.20
11:
45–68 2.62 3.31 4.44 2.51
16:
20 2.27 ND 1.47 2.89
20:
60: ND ND 2.36 2.99
Empirical signiﬁcant threshold 3.17 3.40 4.05 3.85
Empirical suggestive threshold 2.40 2.48 3.05 2.89
NOTE.—Suggestive NPL scores are in boldface; signiﬁcant NPL scores are in boldface italics. ND p not determined.
88 female subjects. The “call rate” in the HMA10K assay
is the percentage of SNPs for which a deﬁnitive genotype
call was obtained in any given sample. If the assay is
performing optimally, call rates will exceed 95% (Ken-
nedy et al. 2003). Across the 148 samples in our study,
the mean call rate was 96.92% (table 1). Of the 25 fam-
ilies we analyzed, 20 had mean call rates of 97%,
whereas 5 families had mean call rates ranging from
91%–95%. The distribution of genotype calls across the
25-family data set was approximately equal among AA,
AB, and BB genotypes, with slightly more heterozygous
calls observed (table 1). The greatest sources of variability
in the call rate appeared to be the family origin of the
sample (ﬁg. 1). Figure 1 indicates that the lowest call rates
we obtained were from the families that originated in the
city of Coimbra, where the DNA was extracted before
shipment to the United States. These families were some
of the ﬁrst ascertained for bipolar disorder and are thus
among the oldest samples in the Portuguese Island Col-
lection. Samples from the same family were generally col-
lected and batch processed. Thus, we interpret these ob-
servations to indicate sample age and handling (repeated
freeze thawing or variation in experimenter technique) as
potential impediments to optimal assay performance. In
fact, we highly recommend that researchers employ fresh
DNA samples from sources with high quality-control
measures for best assay performance.
Error Rates
To estimate the error rates of the assay, we performed
two types of analyses. First, in the 60 male subjects used
for this analysis, we examined the genotype calls of the
X chromosome, which was interrogated by a total of
301 SNP probe sets. Since males inherit only a single X
chromosome, they must be completely homozygous for
each SNP. Of the total of 18,060 calls, we observed only
a single heterozygous call in these 60 males, yielding an
error rate of 1 in 18,060, or 0.0055%, for the X
chromosome.
To further probe this issue, we also looked for ge-
notyping errors of transmission in the X chromosome,
by examining 18 mother-son pairings in the 25 families
for inaccurate genotypes (sons not matching mothers at
maternal homozygous alleles). On average, !200 alleles
were found with homozygous maternal genotype calls
among these 18 pairings. Only 2 of 13,500 individual
SNPs analyzed in this manner were determined to have
incorrect calls. One of these errors was in the maternal
genotype (determined because all three male offspring
shared the same genotype in this family), whereas the
other SNP genotyping error could have been in either
the maternal or the offspring genotype. Thus, a reason-
able approximation of transmission errors in our data
set is 2 in 3,500, or 0.057% per generation. It is im-
portant to note that, while performing linkage analysis,
MERLIN automatically discards SNPs with these types
of errors. Moreover, the data presented in the present
study were analyzed after performing the “Pedwipe”
command in MERLIN to permanently remove such er-
rors. In our assays, the total number of SNPs included
after mapping and removing errors was 11,190.
Figure 2 Linkage signals obtained with 10-cM–spaced and 4-cM–spaced microsatellite assays, as well as the HMA10K SNP genotyping
assay. These assays were performed on the same individuals from each of the same 12 families. Note the high correlation of the different assays
in general, and that for both chromosomes 6 and 11, the SNP assay detected major linkage peaks at locations where the information content
and coverage of the microsatellite panels were relatively low. Mb, megabase position; MSM, microsatellite markers.
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Table 3
Chromosome 6 Linkage Peak Candidate Genes
Position of SNP (Mb) Gene(s) Position of Gene (Mb)
125.438 Tumor protein D52-like 1 125.505–125.521
125.769 CGI 130 protein 126.532–125.538
125.798 CGI 130 protein 126.532–125.538
HEY2 hairy/enhancer-of-split related 2 126.006–126.018
ERAP140/NCOA7 126.142–126.187
126.371 Hypothetical protein AK094706 126.176–126.187
Hypothetical protein AL834442 126.111–126.188
NOTE.—Maximum NPL position appears in boldface.
Figure 3 NPL analysis of 25 families with bipolar disorder from the Portuguese Island Collection. The number of each chromosome is
shown at the top of each plot. The X-axis indicates the physical position (Mb) of the SNP marker. The Y-axis indicates the NPL Z score (black)
or Kong and Cox LOD score (gray). For this scan, the empirical limit for genomewide signiﬁcance was an NPL score of 3.85 and a LOD score
of 3.15. Note that only the peak on chromosome 6 at 125.8 Mb was signiﬁcant when both NPL Z and LOD thresholds were used.
Linkage Analysis
We present a comparison of the low- and intermediate-
density microsatellite scans and the higher-density SNP
assay by use of the 12-family data set, and we report
the results of the high-density SNP assay in the larger
25-family data set.
Twelve-Family Genomewide Scan
Our results with the HMA10K assay conﬁrm the ini-
tial ﬁnding of linkages to chromosomes 2, 6, and 11 in
12 of the same families we used for either the 10-cM or
the 4-cM microsatellite screening (table 2) (see Pato et
al., in press). Moreover, throughout much of chromo-
somes 6 and 11, the linkage results obtained with the
different assays showed a remarkable degree of similarity
(ﬁg. 2). However, the increased coverage and informa-
tion content of the HMA10K assay in these families has
now raised the maximum NPL Z and/or LOD scores on
chromosomes 6 and 11 beyond the level of genomewide
signiﬁcance. These thresholds were empirically deter-
mined to be an NPL score of 4.05 and a nonparametric
LOD score of 2.60 (see the “Material and Methods”
section) (table 2). Speciﬁcally, the 12-family data set
achieved an NPL score of 3.87 and LOD score of 2.79
at position 125.8 Mb on chromosome 6q22 and an NPL
score of 4.44 and LOD scores of 2.62 at position 48.5
Mb on chromosome 11p11. Inspection of the positions
of these signiﬁcant peaks on chromosomes 6 and 11 in
the HMA10K assay indicates that they are in regions
where the information content and coverage of the mi-
crosatellite marker assays were relatively low and po-
tentially insufﬁcient for peak detection. In contrast, the
mean information content of the SNP assay was 0.842
(range: 0.739–0.874).
Twenty-ﬁve–Family Genomewide Scan
Empirical thresholds for genomewide signiﬁcance in
the 25 families were established at an NPL score of 3.85
and a nonparametric LOD score of 3.0 (see the “Ma-
terial and Methods” section). The results of the linkage
analysis for this data set (table 2; ﬁg. 3) provided further
validation of the ﬁnding on chromosome 6q22, achiev-
ing a maximumNPL score of 4.20 and amaximumLOD
score of 3.56 at position 125.8 Mb. This peak and the
surrounding region of chromosome 6 that exceeded the
threshold for suggestive genomewide signiﬁcance (NPL
1 2.89) were interrogated by a total of 38 SNPs, with
an average inter-SNP distance of 0.20Mb. At the precise
location of maximal peak height, there were a total of
ﬁve individual SNPs interspaced with six genes (table 3).
Haplotype-based analysis of 55 SNPs spanning this peak
for the 25-family data set with MERLIN failed to in-
dicate any evidence of linkage disequilibrium in this pop-
ulation (not shown). In addition to these ﬁndings on
chromosomes 6 and 11 in the 12- and 25-family data
sets, several other regions of suggestive linkage on chro-
mosomes 2, 4, 16, and 20 have also been identiﬁed in
these families using the HMA10K assay that were largely
undetected with the microsatellite scans of the 12-family
set (table 2). The HMA10K results in the two family
sets are shown in ﬁgure 4 for chromosomes 2, 4, 6, 11,
16, and 20. We note that, in general, the linkage results
obtained with the 25 families were very similar to those
obtained using only 12 families. Moreover, the linkage
signal on chromosome 6q22 at position 125.8 Mb is the
only region that achieves genomewide signiﬁcance for
NPL or LOD scores in both scans. The linkage signal
on chromosome 11p11 that attained genomewide sig-
niﬁcance in the 12 families clearly dropped below that
level for the full 25-family data set, as did peaks on
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Figure 4 Comparison of the 12-family (gray) and 25-family (black) genomewide linkage scans for selected chromosomes showing suggestive
or signiﬁcant linkage (see table 1). The X-axis indicates physical position (Mb). Note that for both scans, the signal on chromosome 6 at
position 125.8 Mb is the only genomic region that achieves genomewide signiﬁcance (of NPL score and/or LOD score).
several other chromosomes, with notable exceptions of
peaks on chromosomes 4 and 20.
Discussion
A direct comparison of the linkage peaks obtained
through the use of microsatellite markers and the
HMA10K assay has indicated a high degree of corre-
spondence between the two approaches in general (ﬁg.
2). However, there are clear instances where the sam-
pling provided by traditional microsatellite approaches
is largely insufﬁcient to detect highly signiﬁcant linkage
peaks. The peaks on chromosomes 6 and 11 that reached
genomewide signiﬁcant levels in the SNP assay are two
examples of this fact. On the basis of the greater infor-
mation content and coverage of the HMA10K assay, its
high level of accuracy, and the ability to rapidly perform
and analyze the data obtained from genomewide scans
with MERLIN and other software, we believe further
use of the assay is warranted.
Major Findings
In a previous study (Pato et al., in press), we reported
suggestive genomewide linkage signals for chromosomes
2, 6, 11, and 19, on the basis of the results obtained
using a 10-cM–spaced microsatellite scan. Mapping
chromosome 6 at 4.2-cM spacing with microsatellite
markers in those 16 Portuguese families raised the NPL
score to 2.59 at the same marker, D6S1021 (104.7 Mb),
on chromosome 6 and revealed an additional peak at
marker D6S1639 (125 Mb), with an NPL score of 3.06.
The ﬁnding on 6q was highlighted in that report because
of its relevance to the results of Dick et al. (2003), who
reported in a study of 250 families with bipolar disorder
a maximum LOD score of 2.2 at marker D6S1021
(104.7Mb) on chromosome 6q, which was subsequently
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raised to a genomewide signiﬁcance level of 3.8 in a
combined analysis of all 399 pedigrees with bipolar dis-
order from their collection.
In the present report, using a new high-density SNP
genotyping array, we have conﬁrmed the initial ﬁnding
of suggestive linkage to chromosomes 2, 6, and 11 in a
subset of the same families used for the microsatellite
screening. Moreover, as a result of the greater infor-
mation content and coverage of the HMA10K assay, we
have achieved a signiﬁcant level of linkage for the peaks
on chromosomes 6 and 11, with maximum NPL and
LOD scores of 4.44 and 2.62, respectively, on chro-
mosome 11 at position 48.5 Mb, and maximum NPL
and LOD scores of 3.87 and 2.79, respectively, on chro-
mosome 6 at position 125.8 Mb. Moreover, with the
complete set of 25 families, we can now clearly establish
a signiﬁcant genomewide ﬁnding with a maximum NPL
score of 4.20 and a maximum LOD score of 3.56 for
the peak on chromosome 6 at position 125.8 Mb.
Relationship to Other Studies
In an extensive nonparametric genomewide linkage
analysis of 153 pedigrees studied through the NIMH
Collaborative Genetics Initiative, McInnis and col-
leagues (2003) reported a single chromosomal region on
16p13 with genomewide signiﬁcance, as well as nomi-
nally signiﬁcant linkage at four additional chromosomal
regions (20p12, 11p15, 6q24, and 10p12). The present
study has reported signiﬁcant or suggestive linkage on
four of these same chromosomes (6, 11, 16, and 20).
The location of our signiﬁcant or suggestive peaks on
these four chromosomes is at least 10 Mb distant (range
11–40 Mb) from each of the peaks reported in that
study, although, in some cases, we have obtained nom-
inally signiﬁcant peaks that are closer in proximity. Sim-
ilarly, in another study of bipolar disorder in families of
Danish origin, Ewald and colleagues (2002) also re-
ported signiﬁcant or suggestive linkage of bipolar dis-
order with regions of chromosomes 1p14-21, 4p16,
6q14-22, 10q26, 12q24.3,and 16p13.3. However, the
locations of their linkage peaks are also somewhat dis-
tant from the ones we obtained in the present study.
Thus, we believe the present results represent novel lo-
calizations of linkage for bipolar disorder. On the other
hand, it is possible that mapping of the families in those
studies with a more comprehensive assay, such as the
HMA10K, may reveal reﬁnement in their localization
that results in greater consistency between our results.
The level of signiﬁcance achieved in this study for the
linkage peak on chromosome 6 rivals those obtained in
any previously reported linkage study of bipolar disorder
(reviewed in Sklar 2002). The fact that we observed this
peak to be signiﬁcant and highly localized in both the
12- and 25-family data sets and that the peak was sig-
niﬁcant using both NPL and Kong and Cox LOD scores
argues in favor of additional research in this genomic
region. We brieﬂy discuss below some of the potential
candidate genes that might contribute to the bipolar phe-
notype in our sample population.
Chromosome 6 Candidate Genes
In the maximal NPL and maximal LOD region iden-
tiﬁed on chromosome 6, position 125.8 Mb, there are
only four known genes and two hypothetical genes (table
3). One of these genes (CGI-130) actually spans the
linkage peak at position 125.8 Mb. The next-closest
genes are located ∼200 kb upstream (tumor protein
D52-like 1) or 350 kb downstream of the linkage sig-
nal peak (HEY2 and ERAP140). It is interesting that,
although the biological role of CGI-130 has never been
studied, both HEY2 and ERAP140 appear to have a
major role in brain function. Therefore, we brieﬂy dis-
cuss some of the potential import of these genes in our
ﬁndings.
HEY2
HEY2 is the mammalian homologue of the Drosoph-
ila melanogaster hairy/enhancer of split 2 gene. The ac-
tion of HEY2 appears to largely revolve around inhi-
bition of the transcriptional activities of the neuronal
basic helix-loop-helix (bHLH) factors, particularly
Mash1 and Math3 (Sakamoto et al. 2003). Neuronal
bHLH genes both promote neuronogenesis and inhibit
gliogenesis. In normal mouse brain development,HEY2
is expressed in the cortical matrix, as well as the retina
and cochlear ganglion (Leimeister et al. 1999). Misex-
pression of the HEY2 transcript by in utero electropor-
ation in mice at 13.5 d gestation (the time when cortical
neurons are being produced) results in a temporary sta-
bilization of the neuronal precursor population that sub-
sequently causes more late-born neurons to arise in the
superﬁcial layers of cortex. On the other hand, when
HEY2 is overexpressed at later stages of mouse brain
development, it actually inhibits neuronogenesis in favor
of gliogenesis (Sakamoto et al. 2003). If there were an
alteration in the HEY2 gene in bipolar disorder, it could
have an inﬂuence on neural cell fate and circuit for-
mation or the regulation of neurogenesis that occurs in
such adult human brain regions as the dentate gyrus
(Eriksson et al. 1998). It is interesting to note that high
levels of stress have also been shown to reduce the
amount of neurogenesis in the adult dentate gyrus (re-
viewed in Gould et al. 2000), and stress itself is one of
the best predictors of relapse in bipolar disorder (Am-
belas and George 1986). This raises the possibility that
modulation of HEY2 expression may be one of the
mechanisms of regulating neurogenesis and long-term
stress adaptation in adult humans.
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ERAP140
Estrogen-receptor associated protein 140 (ERAP140)
is a recently described nuclear receptor coactivator that
is highly abundant in the brain, where its expression is
exclusive to neurons (Shao et al. 2002). The actions of
ERAP140 are believed to be similar to those of other
nuclear receptor coactivators, in that these coactivators
directly regulate the effects of steroid hormones on neu-
rons. These effects are known to inﬂuence transcription
of genes involved in neurodevelopment and neuropro-
tection. Although purely speculative, one possibility is
that alteration of the ERAP140 gene in bipolar disorder
could produce signiﬁcant differences in the responsivity
of neurons to estrogens and steroid hormones. Predic-
tion of the consequences of such an alteration would
depend on knowing which regions of the human brain
would be most affected by this change in responsivity,
information that is lacking at present. The profound
inﬂuence of stress on circulating steroid levels in the
brain, however, is well established (see Gould et al.
2000). Thus, two of the most attractive candidate genes
identiﬁed through our linkage analysis of 25 bipolar
families are known to inﬂuence brain development and
may play a role in the brain’s adaptation to environ-
mental stress.
Conclusions
The HMA10K genotyping assay provides increased
power for detection of signiﬁcant linkage signals, com-
pared with the power of traditional microsatellite
marker panels. The ease, speed, and accuracy withwhich
these assays can be performed and analyzed on high-
quality DNA samples should serve as an impetus to other
researchers searching for clues regarding the pathogen-
esis of human diseases. In our study, we have now ob-
tained strong indications that linkage to a region of chro-
mosome 6q22 is a fairly common feature in Portuguese
families with bipolar disorder. This information will be
of great beneﬁt to us in our efforts to identify candidate
genes for this debilitating psychiatric illness. We tenta-
tively suggest follow-up studies on three promising can-
didate genes, CGI-130, HEY2, and ERAP140.
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